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Abstract A mutant of human immunodeficiency virus type 1 
(HIV-1), which is deficient for Gag precursor cleavage and non-
infectious, was characterized with respect to its defective step in 
the viral replication phase. Upon transfection, the mutant 
produced a normal level of progeny virions as monitored by 
electron microscopy and RNA hybridization. Single-round 
replication assay demonstrated, in contrast, that the mutant 
was defective at the early phase of the replication cycle. 
Furthermore, no viral DNA was detected in the cells infected 
with the mutant. Taken together, it is concluded that maturation 
of Gag precursor protein of HIV-1 is required for an early 
event(s) before or during a coupled process of uncoating/reverse 
transcription. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The functional importance of human immunodeficiency vi-
rus type 1 (HIV-1) protease for viral replication has been well 
documented [1-3]. In HIV-1, structural and enzymatic com-
ponents of the virion are expressed as polyprotein precursors, 
i.e. Gag Íp55») and Gag-Pol (pl60»-poi)[4], respectively, 
which assemble into immature virions on the cytoplasmic 
side of the cell membrane [1]. The HIV-1 protease is part of 
the p l ó O » ^ 0 ' . During and after virion budding from the cell 
membrane, proteolytic processing of the ρ55ίαίί and 
pl60ÍOff-poí polyprotein precursors is initiated by the viral pro-
tease, leading to mature Gag and Pol proteins, condensation 
of the viral core, and hence, infectious virions [1-3]. HIV-1 
can assemble in the absence of functional viral protease, but 
the resultant virions are non-infectious and morphologically 
aberrant [1-3,5]. 
Although it is apparent that the HIV-1 protease functions 
at the late viral replication phase for maturation of progeny 
virions, it is not clear whether the protease is required for 
efficient release of virions from cells, and furthermore, the 
molecular basis for the non-infectivity of virions produced 
in the absence of the protease is not known. In this study, 
we have characterized a protease-deficient mutant of HIV-1 in 
detail to determine its critically defective step in the viral 
replication phase. We demonstrate here that cleavage of 
Gag precursor is essential for the early viral replication phase, 
before and during a process of uncoating/reverse transcrip-
tion. 
*Corresponding author. Fax: (81) (886) 7080. 
2. Materials and methods 
2.1. Cell culture and DNA transfection 
Human CD4+ leukemia cell lines, A3.01 [6], Molt4 clone 8 (M4-8) 
[7], and H9 [8], were maintained in RPMI 1640 medium supplemented 
with 10% heat-inactivated fetal bovine serum. A human colon carci-
noma cell line, SW480 [9], was maintained in Dulbecco's modified 
Eagle medium supplemented with 10% heat-inactivated fetal bovine 
serum. For transfection, uncleaved plasmid DNA was introduced into 
SW480 and leukemia cell lines by the calcium phosphate coprecipita-
tion [9] and modified DEAE-dextran [10] methods, respectively. 
2.2. Western immunoblotting 
Lysates of transfected SW480 cells were processed for Western 
blotting as previously described using a serum from an HIV-1-
infected individual [11]. [125I]Protein A was used to detect viral Gag 
proteins. 
2.3. Electron microscopy (EM) 
Transfected SW480 cells were processed for EM as previously de-
scribed [5]. 
2.4. RNA dot blot hybridization 
Virion RNA was detected by the method as previously described 
[12]. Briefly, the same volume of culture supernatants obtained from 
SW480 cells transfected with wild-type (wt) or mutant clones was 
centrifuged to pellet virions, RNA was extracted from them, and 
RNA dot blot hybridization was performed using a full-length 
pNL432 genome as a probe. Some samples were treated with sodium 
hydroxide (4 N, 60°C for 15 min). 
2.5. CA T and RT assays 
The chloramphenicol acetyltransferase (CAT) [13] and reverse tran-
scriptase (RT) [11] assays have been previously described. 
2.6. Determination of Gag p24 antigen level 
HIV-1 p24 antigen was detected by using a commercial ELISA kit 
(Abbot Laboratories). 
2.7. Single-round replication assay 
The process of HIV-1 replication was quantitatively analyzed by a 
system designated single-round replication assay (SRA) [14,15]. 
2.8. Polymerase chain reaction (PCR) analysis of viral DNA 
Virus samples prepared from transfected SW480 cells were treated 
with DNAse I before infection to CD4+ cells to remove potentially 
contaminated plasmid DNAs. Samples for PCR amplification were 
prepared as described previously [14]. The detailed methods of 
PCR, agarose gel electrophoresis, and Southern blot hybridization 
were also as described previously [14]. 
2.9. DNA constructs 
An infectious molecular clone of HIV-1 designated pNL432 and its 
protease-defective mutant pNL-Hc have been previously described [5]. 
An Env(—) mutant pNL-Nh was constructed from pNL432 as pre-
viously described [14,15]. Plasmids for SRA designated pNLnCAT 
(wt) and pNLnCAT-Nh ienv mutant) were also described previously 
[14,15]. A mutation was introduced into the pro tease-coding region 
of pNLnCAT and designated pNLnCAT-Hc as previously described 
[5]. 
0014-5793/97/S17.00 © 1997 Federation of European Biochemical Societies. All rights reserved. 
P / /S0014-5793 (9 7)01131-9 
228 M. Kawamura et allFEBS Letters 415 (1997) 227-230 
3. Results 
3.1. Phenotypic characterization of the protease-deficient 
mutant 
A plasmid DNA designated pNL-Hc, which carried a mu-
tation in the protease-coding region [5], was transfected into 
SW480 cells [9], and monitored for Gag expression in cells 
and RT production in culture supernatants. As shown in 
Fig. 1A, only the precursor of HIV-1 Gag was detected in 
cells transfected with pNL-Hc. In sharp contrast, mature 
gag gene products were readily seen in cells transfected with 
wt pNL432. Virion production by pNL-Hc into culture fluids 
as monitored by RT assay was relatively low, reaching only 
10-20% of that by pNL432 (Fig. IB). Essentially the same 
results were obtained by the enzyme-linked immunosorbent 
(ELISA) assay of Gag antigen (data not shown). 
Although these data are consistent with those previously 
reported [3,5], we were still concerned about the level of virion 
production. Since only the precursor is produced in cells, 
measuring amounts of virions by RT assay and ELISA could 
result in an underestimation. We therefore monitored the vi-
rions produced from transfected SW480 cells by EM and hy-
bridization. As shown in Fig. 2A, when transfected cells were 
examined by EM, while morphological abnormality of the 
mutant virions (doughnut-shaped) was easily seen, similar 
Fig. 2. Virion production of the protease-deficient mutant. SW480 
cells were transfected with pNL432 (432, wt) or pNL-Hc (He, pro-
tease-deficient), and monitored for production of progeny virions by 
EM (A) [5] and by RNA dot blot without (-) and with (+) sodium 
hydroxide treatment (B) [12]. A: Bar= 100 nm. 
numbers of virions were observed. More quantitative analysis 
by RNA hybridization was performed to substantiate the EM 
observation. The same amount of culture supernatant was 
taken from SW480 cells transfected with pNL432 or pNL-
Hc, subjected to ultracentrifugation, and RNA in the virions 
obtained was detected by hybridization as previously reported 
[12]. As is clear from Fig. 2B, no significant difference in RNA 
contents was detected. 
Due to the effect of the mutation in the protease region 
described above, the NL-Hc virus lacked infectivity for 
A3.01, M4-8, and H9 cells (data not shown). 
Fig. 1. Expression of viral proteins of the protease-deficient mutant. 
SW480 cells were transfected with 20 μg of pNL432 (432, wt), 
pNL-Hc (He, protease-deficient) or pUC19 (Cr, negative control), 
and monitored for the expression of Gag proteins (precursor p55; 
mature products p24 and pi7) by Western blotting (A) [11] and for 
RT production (B) [11], 
3.2. Defective stage of the protease mutant in the viral 
replication cycle 
The pNL-Hc was analyzed for its critical defect in the viral 
replication cycle. For this purpose, a system recently devel-
oped by us and designated SRA [14,15] was used. A proviral 
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Fig. 3. Analysis of late viral replication phase by SRA. Four cell lines were co-transfected with one of three proviral CAT constructs plus 
previ (Rev expression vector), and 48 h later, CAT activity in cells and virion-associated RT activity in the culture supernatants were deter-
mined [14,15]. Relative activity is shown. CAT production is indicative of a normal proceeding of the transcription and translation in the late 
viral replication phase [14,15]. DNA constructs: pNLnCAT, wt; pNLnCAT-Hc, pro tease-deficient; pNLnCAT-Nh, Env(—). 
clone carrying CAT was newly constructed and designated 
pNLnCAT-Hc. Because transfection of a viral DNA clone 
would bypass the early phase of viral replication (adsorption, 
penetration, uncoating/reverse transcription, integration), the 
results in Fig. 2 are consistent with the critical requirement of 
Gag cleavage in the early viral replication stage. 
Fig. 3 shows the results obtained in four cell lines by the 
SRA for the late phase. Three CAT-proviral clones were in-
troduced into the cell lines, and CAT and RT activities were 
determined. Although RT production in the culture superna-
tants by pNL-Hc was relatively low as shown in Fig. IB, CAT 
activity in cells was normal. There was no difference in results 
among the four cell lines. The early phase of viral replication 
was examined by using CAT viruses prepared from SW480 
cells transfected with the three proviral clones. The viruses 
were inoculated into the three cell lines, and CAT production 
was monitored. As demonstrated in Fig. 4, no significant CAT 
activity was expressed in cells infected with the NLnCAT-Hc 
virus relative to that in cells infected with the NLnCAT-Nh, a 
negative control Env(—) virus. There was, again, no cell differ-
ence. 
The defect of the pNL-Hc was further analyzed by moni-
toring viral DNA synthesis (Fig. 5). Virus samples prepared 
from transfected SW480 cells were inoculated into A3.01 cells, 
and at 10 h post-infection, viral DNA was extracted, and 
Southern blot hybridization was performed [14]. As easily 
observed, while viral DNA was seen in cells infected with 
wt NL432, no specific DNA was detected in cells infected 
with the NL-Ffc or the NL-Nh, a negative control Env(—) 
mutant virus. These results were reproduced in several inde-
pendent experiments. 
4. Discussion 
In this study, we confirmed that, while a protease-defective 
mutant of HIV-1 is unable to process the Gag polyprotein 
precursor, morphologically abnormal non-infectious virions 
are produced from transfected cells (Figs. 1 and 2). Also in 
agreement with previous observations, cells transfected with 
the mutant generated much less RT activity than did cells 
transfected with wt clone (Figs. 1 and 3). 
The SRA demonstrated that the transcription and transla-
tion process of the protease-defective mutant was normal (Fig. 
3). Although a relatively low level of progeny virions was 
produced when monitored by RT assay (Fig. lBFig. 3) and 
ELISA, a considerable number of doughnut-shaped virion-
like particles were released from cells transfected with the 
protease-defective mutant clone (Fig. 2A). In addition, culture 
supernatants from the mutant-transfected cells contained a 
normal level of particle-associated viral RNA (Fig. 2B). It is 
quite likely, therefore, that the unprocessed Gag-Pol fusion 
protein had lower specific RT activity and weaker immuno-
reactivity. 
A clear defect in the early viral replication phase was de-
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many in-frame gag mutants appears to be located at this 
step (our unpublished observation). 
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